Public filings / ABT on Yahoo Finance (opens in a new tab)
ABT: insider buying, 13F holders, analyst moves
Abbott Laboratories
A summary of public filings about Abbott Laboratories. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
6 of our 100 managers hold ABT
Combined reported value $243.3M; 2 sold out since Q1 2026.
Holders among our 100 managers: 4 in Q3 2023, 6 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Sanders Capital | $95.3M | 0.10% | Trimmed |
| Southeastern Asset Management | $76.3M | 3.98% | New |
| Tudor Investment | $66.3M | 0.27% | Added |
| Soros Fund Management | $4.1M | 0.05% | Unchanged |
| Gardner Russo & Quinn | $1.0M | 0.01% | Unchanged |
| Polen Capital | $286K | 0.00% | Trimmed |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.